News
Important Only
Lotus Technology Reports Unaudited First Quarter 2025 Financial Results
June 25 (Reuters) - Lotus Technology Inc 5EPy.F:LOTUS TECHNOLOGY REPORTS UNAUDITED FIRST QUARTER 2025 FINANCIAL RESULTSLOTUS TECHNOLOGY INC - Q1 2025 REVENUE REACHES $93 MILLIONFurther company coverage: [5EPy.F]Reuters
Wed, Jun 25
General Mills forecasts downbeat annual profit on macroeconomic uncertainty
June 25 (Reuters) - Pillsbury-owner General Mills GIS.N forecast annual profit below expectations on Wednesday, hurt by weak demand for refrigerated baked goods and snacks amid rising costs in a tariffs-driven, uncertain macroeconomic background.The company expects full-year adjusted profit to be in...Reuters
Wed, Jun 25
Kymera Therapeutics Announces Sanofi Irak4 Collaboration Update
June 25 (Reuters) - Kymera Therapeutics Inc KYMR.O:KYMERA THERAPEUTICS ANNOUNCES SANOFI IRAK4 COLLABORATION UPDATEKYMERA THERAPEUTICS INC - SANOFI TO ADVANCE KYMERA'S KT-485 INTO CLINICAL TESTINGKYMERA THERAPEUTICS INC - ELIGIBLE FOR UP TO $975 MILLION IN MILESTONESKYMERA THERAPEUTICS INC - KT-4...Reuters
Wed, Jun 25
Indaptus Therapeutics Announces Reverse Stock Split
June 25 (Reuters) - Indaptus Therapeutics Inc INDP.O:INDAPTUS THERAPEUTICS ANNOUNCES REVERSE STOCK SPLITINDAPTUS THERAPEUTICS INC - APPROVES ONE-FOR-TWENTY EIGHT REVERSE STOCK SPLITINDAPTUS THERAPEUTICS INC - STOCK TO TRADE ON SPLIT ADJUSTED BASIS FROM JUNE 27Reuters
Wed, Jun 25
The Joint Corp. Signs Binding Agreement To Sell 31 Corporate Clinics In Arizona And New Mexico
June 25 (Reuters) - Joint Corp JYNT.O:THE JOINT CORP. SIGNS BINDING AGREEMENT TO SELL 31 CORPORATE CLINICS IN ARIZONA AND NEW MEXICO AND TO ACQUIRE REGIONAL DEVELOPER RIGHTS IN THE NORTHWEST REGION AND REFRANCHISES FIVE CORPORATE CLINICS IN THE KANSAS CITY REGION, TRACKING TO BECOME LARGEST PURE PLA...Reuters
Wed, Jun 25
Americas Gold And Silver Closes Us$100 MLN Debt Financing
June 25 (Reuters) - Americas Gold and Silver Corporation USA.TO:AMERICAS GOLD AND SILVER CLOSES US$100 MILLION DEBT FINANCING WITH SAF GROUP AND PROVIDES GALENA UPDATEAMERICAS GOLD AND SILVER CORPORATION - TERM LOAN FACILITY INCLUDES $50 MILLION ADVANCED AT CLOSING AND TWO $25 MILLION TRANCHESReuters
Wed, Jun 25
Viking Therapeutics Announces Initiation Of Phase 3 Obesity Clinical Program
June 25 (Reuters) - Viking Therapeutics Inc VKTX.O:VIKING THERAPEUTICS ANNOUNCES INITIATION OF PHASE 3 OBESITY CLINICAL PROGRAM WITH GLP-1/GIP AGONIST VK2735VIKING THERAPEUTICS INC: EXPECT TO REPORT RESULTS OF PHASE 2 VENTURE-ORAL DOSING STUDY IN H2Reuters
Wed, Jun 25
Bio-Thera Solutions Announces First Patient Dosed In Phase 3 Clinical Trial For Bat8006
June 25 (Reuters) - Bio-Thera Solutions Ltd 688177.SS:BIO-THERA SOLUTIONS ANNOUNCES FIRST PATIENT DOSED IN PHASE 3 CLINICAL TRIAL FOR BAT8006, AN ANTIBODY DRUG CONJUGATE TARGETING FOLATE RECEPTOR Α FOR THE TREATMENT OF PLATINUM-RESISTANT OVARIAN CANCERReuters
Wed, Jun 25
South Korea court rejects arrest warrant for ex-President Yoon, Yonhap says
SEOUL, June 25 (Reuters) - A South Korean court has rejected a request to issue an arrest warrant for former President Yoon Suk Yeol, Yonhap News Agency said on Wednesday. A spokesperson for the Seoul Central District Court could not be immediately reached for comment.Reuters
Wed, Jun 25
Sierra Club Foundation moves money away from BlackRock
By Ross Kerber June 25 (Reuters) - Prominent U.S environmental organization Sierra Club Foundation said it will move $10.5 million away from BlackRock BLK.N because the top asset manager has not pressed portfolio companies enough on climate concerns.The money in question is tiny fraction of Black...Reuters
Wed, Jun 25
Biocryst Pharmaceuticals: FDA Extends PDUFA Goal Date For Orladeyo NDA
June 25 (Reuters) - BioCryst Pharmaceuticals Inc BCRX.O:BIOCRYST PHARMACEUTICALS INC - ON JUNE 23, FDA EXTENDS PDUFA GOAL DATE FOR ORLADEYO NDA - SEC FILINGBIOCRYST PHARMACEUTICALS INC - NEW PDUFA TARGET ACTION DATE SET FOR DECEMBER 12, 2025 - SEC FILINGSource text: [ID:n0001171843-25-004091]Reuters
Wed, Jun 25
